Two large insider purchases totaling $10M by major holders OrbiMed and Gordon signal strong conviction. The simultaneous derivative conversions by C-suite and OrbiMed suggest a coordinated equity restructuring or financing event. Monitor for a press release or 8-K detailing the transaction and any upcoming clinical or regulatory catalysts.
Price Chart
Executive Summary
OrbiMed Advisors LLC and Carl L. Gordon, both directors and 10% owners of Electra Therapeutics, made open-market purchases totaling $10.0M at $15.00/share on September 21, 2026. This is a material insider buying cluster from two major institutional holders, representing a strong vote of confidence in the company's prospects.
Key Financial Metrics
Key Facts
- OrbiMed Advisors LLC purchased 333,333 shares for $5.0M on 2026-09-21
- Carl L. Gordon purchased 333,333 shares for $5.0M on 2026-09-21
- Total open-market purchases: $10.0M at $15.00/share
- Both buyers are directors and 10% owners, not routine insiders
- Multiple derivative conversions by CEO, CSO, CTO, and OrbiMed on same date (non-cash, $0 value) — likely related to warrant/option exercises
Financial Impact
$10.0M in open-market purchases by two 10% owners/directors
Risk Factors
- Insider purchases, while bullish, do not guarantee near-term stock appreciation
- Derivative conversions could indicate future dilution if shares are sold
- No public catalyst disclosed alongside the trades
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ETRA-1790199385614 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 29d ago | SC 13G | $11.35 $11.25 | ▼ −0.88% | ▼ −0.68% | $8.52 (−24.93%) |
Sep 28, 2026 29d ago | SC 13G | $11.35 $11.25 | ▼ −0.88% | ▼ −0.68% | $8.52 (−24.93%) |
Sep 25, 2026 4w ago | SC 13D | $11.32 $11.35 | ▲ +0.27% | ▲ +0.45% | $8.52 (−24.73%) |
Sep 23, 2026 4w ago | Insider Cluster | $11.82 $11.55 | ▼ −2.28% | ▼ −2.83% | $8.52 (−27.92%) |
Sep 21, 2026 5w ago | 3 | $13.62 $12.67 | ▼ −6.97% | ▼ −6.25% | $8.52 (−37.44%) |
Sep 18, 2026 5w ago | 424B4 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.52 (−38.79%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.52 (−38.79%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.52 (−38.79%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.52 (−38.79%) |
Sep 18, 2026 5w ago | EFFECT | $13.25 $13.92 | ▲ +5.06% | ▲ +3.51% | $8.52 (−35.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers